Early Alzheimer’s therapies slow progression, easing a caregiver’s load

A Oklahoma City woman relocates to care for her father, diagnosed with mild cognitive impairment due to Alzheimer's, and discovers that early treatment with infusions like Leqembi has kept his condition largely stable for about 18 months. The experience offers relief and time for the family to plan, even as experts caution that such therapies slow decline rather than cure the disease and stress the importance of early detection and caregiver resources.